Boston Scientific Neuromodulation Corporation PSC5210W ユーザーズマニュアル
Introduction
5
opioids. Mean follow-up was 2.1 + 0.3 years. This analysis supports
the use of SCS for intractable low back and leg pain.
the use of SCS for intractable low back and leg pain.
In this study, 7 (17%) patients suffered complications after implanta-
tion of the device; 5 (12%) patients required repositioning of catheter
type electrodes and 2 patients required revision of the stimulator gen-
erator.
tion of the device; 5 (12%) patients required repositioning of catheter
type electrodes and 2 patients required revision of the stimulator gen-
erator.